While rich in TB bacteria required for testing, collecting sputum is difficult, making it inefficient for large-scale community testing. Sputum testing is also unfeasible in about 25% of symptomatic ...

Tuberculosis (TB) continues to be one of the world's leading causes of infectious disease-related illness and death. Despite being treatable, gaps in screening and diagnosis have allowed the disease ...

A new strategy for tuberculosis (TB) screening provides a solution to problems with current TB screening, which does not always accurately detect disease. Simultaneously screening for both active and ...

While for the past 30 years, the incidence of active tuberculosis (TB) in the US has been lower than the global incidence, untreated latent TB infection (LTBI) is thought to account for the majority ...

A new era in tuberculosis care has begun with the introduction of a highly affordable molecular test, priced at just $2.60.

Please provide your email address to receive an email when new articles are posted on . “I think it is prudent for people who are managing patients who may be at a greater risk for TB, either because ...

The proposal comes as Delhi is behind key targets under its TB Mukt Bharat Abhiyaan, with the September 30 deadline ...

Please provide your email address to receive an email when new articles are posted on . Latent tuberculosis infection screening in patients with hidradenitis suppurativa who are treated with TNF alpha ...

More than 10 million people develop tuberculosis (TB) each year, yet about 40% go undiagnosed. The main culprit is reliance on sputum-based testing, which many patients—particularly those who are ...